News & Articles

New social media channels will better serve the clinical community by making it even easier to stay up to date

Brand new event designed to bring together everyone working in the clinical laboratory science industry

Discover how sustainability, efficiency, automation and other trends are impacting diagnostic innovation and improving healthcare outcomes

Introducing hemolysis detection in point-of-care blood gas testing for the first time

Activities highlight comprehensive diagnostics solutions to help effectively assess clinical risk and diagnose disease, advance precision medicine and further clinical research

New funding to advance Truvian’s clinical trials to secure FDA clearance for its blood testing platform

Understand the importance of fostering cross-department collaboration for an optimal antimicrobial stewardship program

From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market

NT‑proBNPII Assay now part of Atellica cardiac testing menu

Professor of Emergency Medicine at the University of Manchester highlights the promise of point-of-care high-sensitivity troponin assays in the emergency department

Explore the modern point-of-care ecosystem and its impact on healthcare delivery

An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare

A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways

SelectScience clinical webinars can be added to HCPC and IBMS portfolios as evidence of CPD

Discover how modern quality control (QC) principles can enhance operational efficiency and healthcare outcomes

The inaugural BOOM Summit successfully convened 500 participants from across Europe at Messe Basel

ASTar enables rapid therapeutic response to sepsis directly from a positive blood culture

Highlighting the benefits that point-of-care testing can deliver for cost-efficient healthcare pathways

Smartphone-sized laboratory – Sepsis IVD grade test based on cutting-edge BioMEMS technology is a joint development objective

The analyzer promises to provide a cost-effective, comprehensive, and reliable solution for rapid point-of-care testing

Point-of-care HIV diagnostic testing for infants and early detection of HIV infections

Clinicians can now get results at the patient's bedside, making the test accessible at urgent care clinics and other healthcare settings

PATHFAST hs-cTnI-II becomes first and only hs-cTn test cleared for point-of-care use in the United States, delivering results up to three times faster than core lab testing

The device promises rapid discrimination between benign and malignant epithelial ovarian cysts within 15 minutes

David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers